ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,462Medicare Part D Prescriptions Filled, Including Refills

Rank: 322 out of 890

$475K Total Retail Price of All Prescriptions

Rank: 259 out of 890

271 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 271 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

37% of this provider’s 271 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 3,557 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 595 295 S3 1 3
ATORVASTATIN CALCIUM 219 119 2 13
OXYCODONE HCL 218 39 S2 3 123
AMLODIPINE BESYLATE 208 149 4 1
METFORMIN HCL 200 102 5 6
HYDROCHLOROTHIAZIDE 191 118 6 9
ZOLPIDEM TARTRATE 183 83 7 19
FUROSEMIDE 159 77 8 7
LEVOTHYROXINE SODIUM 145 108 9 2
GABAPENTIN 137 33 10 12
NEXIUM 133 54 11 14
METOPROLOL SUCCINATE 118 83 12 17
PRAVASTATIN SODIUM 114 87 13 10
LISINOPRIL 109 73 14 4
OMEPRAZOLE 99 44 15 8
CARISOPRODOL 95 11 R 16 69
ENDOCET 92 0 S2 17 218
AMITRIPTYLINE HCL 91 40 R 18 43
CARVEDILOL 89 35 19 22
POTASSIUM CHLORIDE 88 53 20 11
NIFEDIPINE ER 83 58 21 75
TRAZODONE HCL 81 26 22 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 43 23 21
CRESTOR 76 18 24 25
OPANA ER 73 13 S2 25 345
FOSINOPRIL SODIUM 72 34 26 184
ONGLYZA 67 47 27 146
SIMVASTATIN 66 21 28 5
ATENOLOL 65 37 29 23
CITALOPRAM HBR 62 42 30 20
FENTANYL 61 13 S2 31 151
QUINAPRIL HCL 59 18 32 116
IBUPROFEN 58 0 33 101
TRAMADOL HCL 56 25 34 16
CLONIDINE HCL 53 14 35 35
TAMSULOSIN HCL 52 21 36 32
CYMBALTA 51 0 37 45
DONEPEZIL HCL 50 47 38 30
OXYCONTIN 50 0 S2 38 213
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.